Oxford Investment Consultants LLP

Founder and CEO of Caristo Diagnostics, a consultant cardiologist with a background in cardiovascular clinical trials and therapeutics, including a decade in drug discovery.

Founder of OTIF Ventures and co-founder/partner of Sloane Robinson LLP, a global listed-equities investment manager focused on Asian and emerging markets. Active early-stage tech and biotech investor with a focus on Oxford spinouts, founding partner of Technikos, and honorary fellow of Keble College, Oxford.

Leads the UK's superconducting quantum computing development at the QCS Hub and is principal investigator at the Leek Lab in Oxford, where he and his team developed OQC's core Coaxmon IP.

Founder of OTIF Ventures and Ocean Infinity, and Senior Partner of Windsor Private Office providing wealth management to high-net-worth individuals and family offices. A serial entrepreneur experienced with EIS-qualifying businesses and a former executive director of the British Racing Drivers' Club.

Former partner at law firm Latham & Watkins (until 2017) with a career spanning telecommunications, technology, finance and law across multiple continents. Has served on boards of technology, healthcare, IT, financial, education and HR companies.

Joined OTIF Ventures in 2018 after 15 years managing the University of Oxford's technology spinout portfolio as Director of Oxford Spinout Equity Management. Brings over 25 years of venture experience across technology and life science spinouts including NaturalMotion, Oxitec, Oxford Immunotec, Immunocore and Adaptimmune.

Joined OTIF Ventures in 2019 with over 16 years in finance focused on valuation and transactions in software and computer services. Previously a Director at PwC leading South-East valuations; a Chartered Management Accountant who serves on three company boards and writes for TechMarketView.

Has 20 years of investment management experience, previously at Sloane Robinson. Portfolio manager of Technikos LLP, a biomedical engineering fund, and holds board roles at Oxford spinouts including Caristo Diagnostics and Oxford Brain Diagnostics.

Joined OTIF Ventures in 2019 with over seven years in venture capital, focusing on deeptech and cleantech investments. Board Director of Nitech Solution and Board Observer of Oxford Space Systems; previously at New Street Research and Seraphim Capital.

Joined OTIF Ventures in 2023 focusing on life science investments. A former NHS medical doctor who previously advised family offices and non-profits on impact investment at New Philanthropy Capital; serves as Board Director at Panda Surgical and Board Observer at SpyBiotech and Biofidelity.